Pulmonary edema explained

Pulmonary edema
Field:Cardiology, critical care medicine pulmonology
Synonyms:Pulmonary oedema
Symptoms:Progressive dyspnea, cough, fever, cyanosis, tachycardia
Complications:ARDS, respiratory failure
Causes:Cardiogenic, Noncardiogenic (pneumonia, inhalation injury, sepsis, airway obstruction, high altitude)
Diagnosis:Medical imaging, lab tests, ECG, echocardiography
Treatment:Supplemental oxygen, diuretics, treat underlying disease process

Pulmonary edema (British English: oedema), also known as pulmonary congestion, is excessive fluid accumulation in the tissue or air spaces (usually alveoli) of the lungs.[1] This leads to impaired gas exchange, most often leading to shortness of breath (dyspnea) which can progress to hypoxemia and respiratory failure. Pulmonary edema has multiple causes and is traditionally classified as cardiogenic (caused by the heart) or noncardiogenic (all other types not caused by the heart).[2] [3]

Various laboratory tests (CBC, troponin, BNP, etc.) and imaging studies (chest x-ray, CT scan, ultrasound) are often used to diagnose and classify the cause of pulmonary edema.[4] [5] [6]

Treatment is focused on three aspects:

Pulmonary edema can cause permanent organ damage, and when sudden (acute), can lead to respiratory failure or cardiac arrest due to hypoxia.[7] The term edema is from the Greek Greek, Ancient (to 1453);: οἴδημα (oidēma, "swelling"), from οἰδέω (oidéō, "(I) swell").[8]

Pathophysiology

The amount of fluid in the lungs is governed by multiple forces and is visualized using the Starling equation. There are two hydrostatic pressures and two oncotic (protein) pressures that determine the fluid movement within the lung air spaces (alveoli). Of the forces that explain fluid movement, only the pulmonary wedge pressure is obtainable via pulmonary artery catheterization.[9] Due to the complication rate associated with pulmonary artery catheterization, other imaging modalities and diagnostic methods have become more popular.[10] Imbalance in any of these forces can cause fluid movement (or lack of movement) causing a buildup of fluid where it should not normally be. Although rarely clinically measured, these forces allow physicians to classify and subsequently treat the underlying cause of pulmonary edema.

Classification

Pulmonary edema has a multitude of causes, and is typically classified as cardiogenic or noncardiogenic.

Cardiogenic pulmonary edema is caused by increased hydrostatic pressure causing increased fluid in the pulmonary interstitium and alveoli.

Noncardiogenic causes are associated with the oncotic pressure as discussed above causing malfunctioning barriers in the lungs (increased microvascular permeability).[11]

Cardiogenic

Cardiogenic pulmonary edema is typically caused by either volume overload or impaired left ventricular function. As a result, pulmonary pressures rises from the normal average of 15 mmHg.[12] As the pulmonary pressure rises, these pressures overwhelm the barriers and fluid enters the alveoli when the pressure is above 25 mmHg.[13] Depending whether the cause is acute or chronic determines how fast pulmonary edema develops and the severity of symptoms. Some of the common causes of cardiogenic pulmonary edema include:

Flash pulmonary edema

Flash pulmonary edema is a clinical syndrome that begins suddenly and accelerates rapidly. Essentially all patients will present to the emergency department by ambulance.

The initiating acute event often a vascular event such as intense vasoconstriction and not a cardiac event such as myocardial infarction. The most noticeable abnormality is edema of the lungs. Nevertheless it is a cardiovascular disease not a pulmonary disease. It is also known by other appellations including sympathetic crashing acute pulmonary edema (SCAPE).[17] It is often associated with severe hypertension[18] Typically, patients with the syndrome of flash pulmonary edema do not have chest pain are often not recognized as having a cardiovascular disease. Treatment of FPE should include reducing systemic vascular resistance with nitroglycerin, providing supplemental oxygenation, and decreasing left ventricular filling pressure. Effective treatment is evident by a decrease in dyspnea and normalization of vital signs. Important targets of therapy such as reduced systemic vascular resistance and reduced left atrial pressure are difficult if not impossible to monitor.[19]

Recurrence of FPE is thought to be associated with hypertension[20] and may signify renal artery stenosis.[21] Prevention of recurrence is based on managing or preventing hypertension, coronary artery disease, renovascular hypertension, and heart failure.

Noncardiogenic

Noncardiogenic pulmonary edema is caused by increased microvascular permeability (increased oncotic pressure) leading to increased fluid transfer into the alveolar spaces. The pulmonary artery wedge pressure is typically normal as opposed to cardiogenic pulmonary edema where the elevated pressure is causing the fluid transfer. There are multiple causes of noncardiogenic edema with multiple subtypes within each cause. Acute respiratory distress syndrome (ARDS) is a type of respiratory failure characterized by rapid onset of widespread inflammation in the lungs. Although ARDS can present with pulmonary edema (fluid accumulation), it is a distinct clinical syndrome that is not synonymous with pulmonary edema.

Direct lung injury

Acute lung injury may cause pulmonary edema directly through injury to the vasculature and parenchyma of the lung, causes include:

Indirect lung injury

Special causes

Some causes of pulmonary edema are less well characterized and arguably represent specific instances of the broader classifications above.

Signs and symptoms

The most common symptom of pulmonary edema is dyspnea and may include other symptoms relating to inadequate oxygen (hypoxia) such as fast breathing (tachypnea), tachycardia and cyanosis. Other common symptoms include coughing up blood (classically seen as pink or red, frothy sputum), excessive sweating, anxiety, and pale skin. Other signs include end-inspiratory crackles (crackling sounds heard at the end of a deep breath) on auscultation and the presence of a third heart sound.

Shortness of breath can manifest as orthopnea (inability to breathe sufficiently when lying down flat due to breathlessness) and/or paroxysmal nocturnal dyspnea (episodes of severe sudden breathlessness at night). These are common presenting symptoms of chronic and cardiogenic pulmonary edema due to left ventricular failure.

The development of pulmonary edema may be associated with symptoms and signs of "fluid overload" in the lungs; this is a non-specific term to describe the manifestations of right ventricular failure on the rest of the body. These symptoms may include peripheral edema (swelling of the legs, in general, of the "pitting" variety, wherein the skin is slow to return to normal when pressed upon due to fluid), raised jugular venous pressure and hepatomegaly, where the liver is excessively enlarged and may be tender or even pulsatile.

Additional symptoms such as fever, low blood pressure, injuries or burns may be present and can help characterize the cause and subsequent treatment strategies.

Diagnosis

There is no single test for confirming that breathlessness is caused by pulmonary edema – there are many causes of shortness of breath; but there are methods to suggest a high probability of an edema.

Lab tests

Low oxygen saturation in blood and disturbed arterial blood gas readings support the proposed diagnosis by suggesting a pulmonary shunt. Blood tests are performed for electrolytes (sodium, potassium) and markers of renal function (creatinine, urea). Elevated creatine levels may suggest a cardiogenic cause of pulmonary edema. Liver enzymes, inflammatory markers (usually C-reactive protein) and a complete blood count as well as coagulation studies (PT, aPTT) are also typically requested as further diagnosis. Elevated white blood cell count (WBC) may suggest a non-cardiogenic cause such as sepsis or infection. B-type natriuretic peptide (BNP) is available in many hospitals, sometimes even as a point-of-care test. Low levels of BNP (<100 pg/ml) suggest a cardiac cause is unlikely, and suggest noncardiogenic pulmonary edema.

Imaging tests

Chest X-ray has been used for many years to diagnose pulmonary edema due to its wide availability and relatively cheap cost. A chest X-ray will show fluid in the alveolar walls, Kerley B lines, increased vascular shadowing in a classical batwing peri-hilum pattern, upper lobe diversion (biased blood flow to the superior parts instead of inferior parts of the lung), and possibly pleural effusions. In contrast, patchy alveolar infiltrates are more typically associated with noncardiogenic edema.

Lung ultrasounds, employed by a healthcare provider at the point of care, is also a useful tool to diagnose pulmonary edema; not only is it accurate, but it may quantify the degree of lung water, track changes over time, and differentiate between cardiogenic and non-cardiogenic edema.[35] Lung ultrasound is recommended as the first-line method due to its wide availability, ability to be performed bedside, and wide diagnostic utility for other similar diseases.

Especially in the case of cardiogenic pulmonary edema, urgent echocardiography may strengthen the diagnosis by demonstrating impaired left ventricular function, high central venous pressures and high pulmonary artery pressures leading to pulmonary edema.

Prevention

In those with underlying heart or lung disease, effective control of congestive and respiratory symptoms can help prevent pulmonary edema.[36]

Dexamethasone is in widespread use for the prevention of high altitude pulmonary edema. Sildenafil is used as a preventive treatment for altitude-induced pulmonary edema and pulmonary hypertension.[37] [38] Sildenafil's mechanism of action is via phosphodiesterase inhibition which raises cGMP, resulting in pulmonary arterial vasodilation and inhibition of smooth muscle cell proliferation and indirectly fluid formation in the lungs.[39] While this effect has only recently been discovered, sildenafil is already becoming an accepted treatment for this condition, in particular in situations where the standard treatment of rapid descent (acclimatization) has been delayed for some reason.[40]

Management

The initial management of pulmonary edema, irrespective of the type or cause, is supporting vital functions while edema lasts. Hypoxia may require supplementary oxygen to balance blood oxygen levels, but if this is insufficient then again mechanical ventilation may be required to prevent complications caused by hypoxia.[41] Therefore, if the level of consciousness is decreased it may be required to proceed to tracheal intubation and mechanical ventilation to prevent airway compromise. Treatment of the underlying cause is the next priority; pulmonary edema secondary to infection, for instance, would require the administration of appropriate antibiotics or antivirals.[2] [3]

Cardiogenic pulmonary edema

Acute cardiogenic pulmonary edema often responds rapidly to medical treatment.[42] Positioning upright may relieve symptoms. A loop diuretic such as furosemide is administered, often together with morphine to reduce respiratory distress.[42] Both diuretic and morphine may have vasodilator effects, but specific vasodilators may be used (particularly intravenous glyceryl trinitrate or ISDN) provided the blood pressure is adequate.[42]

Continuous positive airway pressure and bilevel positive airway pressure (CPAP/BiPAP) has been demonstrated to reduce mortality and the need of mechanical ventilation in people with severe cardiogenic pulmonary edema.[43]

It is possible for cardiogenic pulmonary edema to occur together with cardiogenic shock, in which the cardiac output is insufficient to sustain an adequate blood pressure to the lungs. This can be treated with inotropic agents or by intra-aortic balloon pump, but this is regarded as temporary treatment while the underlying cause is addressed and the lungs recover.[42]

Prognosis

As pulmonary edema has a wide variety of causes and presentations, the outcome or prognosis is often disease-dependent and more accurately described in relation to the associated syndrome. It is a major health problem, with one large review stating an incidence of 7.6% with an associated in hospital mortality rate of 11.9%.[2] Generally, pulmonary edema is associated with a poor prognosis with a 50% survival rate at one year, and 85% mortality at six years.[44]

Notes and References

  1. Book: Dorland's illustrated medical dictionary . 2 May 2011 . Saunders/Elsevier . 978-1-4160-6257-8 . 593 . 32nd.
  2. Assaad S, Kratzert WB, Shelley B, Friedman MB, Perrino A . Assessment of Pulmonary Edema: Principles and Practice . Journal of Cardiothoracic and Vascular Anesthesia . 32 . 2 . 901–914 . April 2018 . 29174750 . 10.1053/j.jvca.2017.08.028 .
  3. Ware LB, Matthay MA . Clinical practice. Acute pulmonary edema . The New England Journal of Medicine . 353 . 26 . 2788–2796 . December 2005 . 16382065 . 10.1056/NEJMcp052699 .
  4. Lindow T, Quadrelli S, Ugander M . Noninvasive Imaging Methods for Quantification of Pulmonary Edema and Congestion: A Systematic Review . JACC. Cardiovascular Imaging . 16 . 11 . 1469–1484 . November 2023 . 37632500 . 10.1016/j.jcmg.2023.06.023 . free .
  5. Guo L, Yang X, Yang B, Tang G, Li C . Prevalence, in-hospital mortality, and factors related to neurogenic pulmonary edema after spontaneous subarachnoid hemorrhage: a systematic review and meta-analysis . Neurosurgical Review . 46 . 1 . 169 . July 2023 . 37432487 . 10335949 . 10.1007/s10143-023-02081-6 .
  6. Komiya K, Akaba T, Kozaki Y, Kadota JI, Rubin BK . A systematic review of diagnostic methods to differentiate acute lung injury/acute respiratory distress syndrome from cardiogenic pulmonary edema . Critical Care . 21 . 1 . 228 . August 2017 . 28841896 . 6389074 . 10.1186/s13054-017-1809-8 . free .
  7. Siddiqi TJ, Usman MS, Rashid AM, Javaid SS, Ahmed A, Clark D, Flack JM, Shimbo D, Choi E, Jones DW, Hall ME . 6 . Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-Analysis . Journal of the American Heart Association . 12 . 14 . e029355 . July 2023 . 37421281 . 10382109 . 10.1161/JAHA.122.029355 .
  8. , .
  9. Patel MR, Bailey SR, Bonow RO, Chambers CE, Chan PS, Dehmer GJ, Kirtane AJ, Wann LS, Ward RP . 6 . ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons . Journal of the American College of Cardiology . 59 . 22 . 1995–2027 . May 2012 . 22578925 . 10.1016/j.jacc.2012.03.003 . free .
  10. Rajaram SS, Desai NK, Kalra A, Gajera M, Cavanaugh SK, Brampton W, Young D, Harvey S, Rowan K . 6 . Pulmonary artery catheters for adult patients in intensive care . The Cochrane Database of Systematic Reviews . 2013 . 2 . CD003408 . February 2013 . 23450539 . 6517063 . 10.1002/14651858.CD003408.pub3 . CD003408 .
  11. Book: Textbook of critical care . 2024 . Elsevier . 978-0-323-75929-8 . Vincent J, Moore FA, Bellomo R, Marini JJ . 8th . Amsterdam .
  12. http://www.nhlbi.nih.gov/health/dci/Diseases/pah/pah_what.html What Is Pulmonary Hypertension?
  13. Book: Adair OV . Cardiology secrets . Elsevier Health Sciences . 2001 . 1-56053-420-6 . 2nd . Chapter 41, page 210.
  14. Alerhand S, Adrian RJ, Long B, Avila J . Pericardial tamponade: A comprehensive emergency medicine and echocardiography review . The American Journal of Emergency Medicine . 58 . 159–174 . August 2022 . 35696801 . 10.1016/j.ajem.2022.05.001 . 248620419 .
  15. MacIver DH, Clark AL . The vital role of the right ventricle in the pathogenesis of acute pulmonary edema . The American Journal of Cardiology . 115 . 7 . 992–1000 . April 2015 . 25697920 . 10.1016/j.amjcard.2015.01.026 .
  16. Siddiqi TJ, Usman MS, Rashid AM, Javaid SS, Ahmed A, Clark D, Flack JM, Shimbo D, Choi E, Jones DW, Hall ME . 6 . Clinical Outcomes in Hypertensive Emergency: A Systematic Review and Meta-Analysis . Journal of the American Heart Association . 12 . 14 . e029355 . July 2023 . 37421281 . 10382109 . 10.1161/JAHA.122.029355 .
  17. 6 . Siddiqua N, Mathew R, Sahu AK, Jamshed N, Bhaskararayuni J, Aggarwal P, Kumar A, Khan MA . January 2024 . High-dose versus low-dose intravenous nitroglycerine for sympathetic crashing acute pulmonary edema: a randomised controlled trial . Emergency Medicine Journal . 41 . 2 . 96–102 . 10.1136/emermed-2023-213285 . 38050078 . 265507643.
  18. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, Little WC . January 2001 . The pathogenesis of acute pulmonary edema associated with hypertension . The New England Journal of Medicine . 344 . 1 . 17–22 . 10.1056/NEJM200101043440103 . 11136955 . free.
  19. Long B, Koyfman A, Gottlieb M . November 2018 . Management of Heart Failure in the Emergency Department Setting: An Evidence-Based Review of the Literature . The Journal of Emergency Medicine . 55 . 5 . 635–646 . 10.1016/j.jemermed.2018.08.002 . 30266198 . 52884356.
  20. Kramer K, Kirkman P, Kitzman D, Little WC . September 2000 . Flash pulmonary edema: association with hypertension and reoccurrence despite coronary revascularization . American Heart Journal . 140 . 3 . 451–455 . 10.1067/mhj.2000.108828 . 10966547.
  21. 6 . Pickering TG, Herman L, Devereux RB, Sotelo JE, James GD, Sos TA, Silane MF, Laragh JH . September 1988 . Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation . Lancet . 2 . 8610 . 551–552 . 10.1016/S0140-6736(88)92668-2 . 2900930 . 36141498.
  22. Hampson NB, Dunford RG . Pulmonary edema of scuba divers . Undersea & Hyperbaric Medicine . 24 . 1 . 29–33 . 1997 . 9068153 . usurped . 2008-09-04 . https://web.archive.org/web/20100617040315/http://archive.rubicon-foundation.org/2388 . 2010-06-17 .
  23. Cochard G, Arvieux J, Lacour JM, Madouas G, Mongredien H, Arvieux CC . Pulmonary edema in scuba divers: recurrence and fatal outcome . Undersea & Hyperbaric Medicine . 32 . 1 . 39–44 . 2005 . 15796313 . usurped . 2008-09-04 . https://web.archive.org/web/20080920063707/http://archive.rubicon-foundation.org/4032 . September 20, 2008 .
  24. Kumar M, Thompson PD . A literature review of immersion pulmonary edema . The Physician and Sportsmedicine . 47 . 2 . 148–151 . May 2019 . 30403902 . 10.1080/00913847.2018.1546104 . 53209012 .
  25. News: 2016-06-17 . Transfusion-related acute lung injury (TRALI) . 2016-12-03 . Professional Education.
  26. Papaioannou V, Terzi I, Dragoumanis C, Pneumatikos I . Negative-pressure acute tracheobronchial hemorrhage and pulmonary edema . Journal of Anesthesia . 23 . 3 . 417–420 . 2009 . 19685125 . 10.1007/s00540-009-0757-0 . 9616605 .
  27. Hines, Roberta L. and Marschall, Katherine. Stoelting's Anesthesia and Co-Existing Disease. 6th edition. 2012. pages 178 and 179.
  28. Web site: 2018-08-08 . Pulmonary edema . Mayo Clinic.
  29. O'Leary R, McKinlay J . Neurogenic pulmonary oedema. Continuing Education in Anaesthesia, Critical Care & Pain. 2011. 11. 3. 87–92. 10.1093/BJACEACCP/MKR006. 18066655. free.
  30. News: 2016-06-02 . Adverse Reactions . https://web.archive.org/web/20161220033454/https://professionaleducation.blood.ca/en/transfusion/clinical-guide/adverse-reactions . 2016-12-20 . 2016-12-03 . Professional Education.
  31. Boyle AJ, Mac Sweeney R, McAuley DF . Pharmacological treatments in ARDS; a state-of-the-art update . BMC Medicine . 11 . 166 . August 2013 . 23957905 . 3765621 . 10.1186/1741-7015-11-166 . free .
  32. Luks AM . Do we have a "best practice" for treating high altitude pulmonary edema? . High Altitude Medicine & Biology . 9 . 2 . 111–114 . 2008 . 18578641 . 10.1089/ham.2008.1017 .
  33. Web site: Bates, M . High altitude pulmonary edema . Altitude Physiology Expeditions . 2007 . 2008-09-04 .
  34. White J, Gray M, Fisher M (1989). Atrax Robustus IPCS InChem
  35. Volpicelli G, Elbarbary M, Blaivas M, Lichtenstein DA, Mathis G, Kirkpatrick AW, Melniker L, Gargani L, Noble VE, Via G, Dean A, Tsung JW, Soldati G, Copetti R, Bouhemad B, Reissig A, Agricola E, Rouby JJ, Arbelot C, Liteplo A, Sargsyan A, Silva F, Hoppmann R, Breitkreutz R, Seibel A, Neri L, Storti E, Petrovic T . 6 . International evidence-based recommendations for point-of-care lung ultrasound . Intensive Care Medicine . 38 . 4 . 577–591 . April 2012 . 22392031 . 10.1007/s00134-012-2513-4 . free .
  36. Book: Light RW, Lee YC . PLEURAL EFFUSIONS Overview. 2006-01-01 . Encyclopedia of Respiratory Medicine. 353–358. Laurent GJ, Shapiro SD . Oxford. Academic Press. en. 10.1016/b0-12-370879-6/00299-4. 978-0-12-370879-3.
  37. Richalet JP, Gratadour P, Robach P, Pham I, Déchaux M, Joncquiert-Latarjet A, Mollard P, Brugniaux J, Cornolo J . 6 . Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension . American Journal of Respiratory and Critical Care Medicine . 171 . 3 . 275–281 . February 2005 . 15516532 . 10.1164/rccm.200406-804OC . pulmonary hypertension .
  38. Perimenis P . Sildenafil for the treatment of altitude-induced hypoxaemia . Expert Opinion on Pharmacotherapy . 6 . 5 . 835–837 . May 2005 . 15934909 . 10.1517/14656566.6.5.835 . 24900169 .
  39. Book: Clark, Michael . Kumar, Parveen J. . Kumar and Clark's clinical medicine . Elsevier Saunders . St. Louis, Mo . 2009 . 783 . 978-0-7020-2993-6.
  40. Fagenholz PJ, Gutman JA, Murray AF, Harris NS . Treatment of high altitude pulmonary edema at 4240 m in Nepal . High Altitude Medicine & Biology . 8 . 2 . 139–146 . 2007 . 17584008 . 10.1089/ham.2007.3055 .
  41. MacIntyre NR . Supporting oxygenation in acute respiratory failure . Respiratory Care . 58 . 1 . 142–150 . January 2013 . 23271824 . 10.4187/respcare.02087 . free .
  42. Cleland JG, Yassin AS, Khadjooi K . Acute heart failure: focusing on acute cardiogenic pulmonary oedema . Clinical Medicine . 10 . 1 . 59–64 . February 2010 . 20408310 . 4954483 . 10.7861/clinmedicine.10-1-59 .
  43. Berbenetz N, Wang Y, Brown J, Godfrey C, Ahmad M, Vital FM, Lambiase P, Banerjee A, Bakhai A, Chong M . 6 . Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema . The Cochrane Database of Systematic Reviews . 2019 . 4 . CD005351 . April 2019 . 30950507 . 6449889 . 10.1002/14651858.CD005351.pub4 .
  44. Zanza C, Saglietti F, Tesauro M, Longhitano Y, Savioli G, Balzanelli MG, Romenskaya T, Cofone L, Pindinello I, Racca G, Racca F . 6 . Cardiogenic Pulmonary Edema in Emergency Medicine . Advances in Respiratory Medicine . 91 . 5 . 445–463 . October 2023 . 37887077 . 10604083 . 10.3390/arm91050034 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pulmonary edema".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.